Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs

Kenji Inoue1, Akira Setogawa1, Risako Higa1, Ryo Moriyama1, Masato Wakakura1, Goji Tomita21Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan; 22nd Department of Ophthalmology, Toho University School of Medicine, Tokyo, JapanIntroduction: Travoprost 0.004%/timolol maleate 0.5% fixed combination eye drops...

Full description

Bibliographic Details
Main Authors:	Inoue K, Setogawa A, Higa R, Moriyama R, Wakakura M, Tomita G
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-02-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/ocular-hypotensive-effect-and-safety-of-travoprost-0004timolol-maleate-a9243

Similar Items

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
by: Kozobolis V, et al.
Published: (2018-11-01)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
by: Costa VP, et al.
Published: (2012-05-01)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
by: Schnober D, et al.
Published: (2015-05-01)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
by: Gado AS, et al.
Published: (2011-12-01)

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
by: Simon Fabian Lerner, et al.
Published: (2017-01-01)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
by: Dubiner HB, et al.
Published: (2012-03-01)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
by: Douglas J Rhee, et al.
Published: (2008-06-01)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
by: Mizoguchi T, et al.
Published: (2012-09-01)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
by: Inoue K, et al.
Published: (2012-04-01)

Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions
by: Campbell JH, et al.
Published: (2014-05-01)

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
by: Michael J Miyashiro, et al.
Published: (2010-11-01)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue K, et al.
Published: (2012-05-01)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
by: David A Godfrey, et al.
Published: (2009-01-01)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015-04-01)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
by: Nakano T, et al.
Published: (2016-12-01)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
by: Inoue K, et al.
Published: (2014-07-01)

Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study
by: Kumar Harsh, et al.
Published: (2002-01-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy
by: Norbert Pfeiffer, et al.
Published: (2010-05-01)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
by: Jaime Pablo Kelly Rigollet, et al.
Published: (2011-02-01)

Investigation on the electrochemical activation process of Li1.20Ni0.32Co0.004Mn0.476O2
by: Daichun Tang, et al.
Published: (2014-08-01)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
by: Hai Wei Wu, et al.
Published: (2017-06-01)

Eficácia do travoprosta 0,004% na redução da pressão intraocular em pacientes com glaucoma
by: Juliana Almodin, et al.

(Ba0.6Pb0.4Sb0.004)TiO3高溫PTCR的性質及劣化之研究
by: Luo, Deng-Gui, et al.
Published: (1991)

Comparison of the effects of antiglaucomatous fixed combinations and patients compliance: Dorzolamide-timolol maleate and latanoprost-timolol maleate
by: Kubilay Çetinkaya, et al.
Published: (2012-03-01)

Transdermal iontophoretic delivery of timolol maleate
by: Mayur Patni, et al.
Published: (2012-12-01)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
by: Heloisa Helena Russ, et al.

Comparison of conjunctival impression cytology between glaucoma patients treated with topical timolol maleate 0.5% and topicallatanoprost 0.005%.
by: Hitam, Wan Hazabbah Wan, et al.
Published: (2004)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
by: Miguel A Teus, et al.
Published: (2009-11-01)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
by: Mizuki Kita, et al.
Published: (2021-08-01)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
by: Anton Hommer, et al.
Published: (2015-01-01)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost&ndash;timolol, bimatoprost/bimatoprost&ndash;timolol, and travoprost/travoprost&ndash;timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
by: Antoine Lafuma, et al.
Published: (2011-03-01)

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy
by: Jordão MLS, et al.
Published: (2014-08-01)

Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate
by: Muge Gulen, et al.
Published: (2014-08-01)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
by: Swati Jagdale, et al.
Published: (2016-01-01)

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
by: Moisseiev E, et al.
Published: (2013-06-01)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
by: Kenji Inoue, et al.
Published: (2014-01-01)

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension
by: Babić Nikola, et al.
Published: (2013-01-01)

Comparação do volume da gota e custo do tratamento dos genéricos de maleato de timolol 0,5% Drop volume and cost of treatment with generic 0.5% timolol maleate preparations
by: João Antonio Prata Junior, et al.
Published: (2004-06-01)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010-11-01)

Cannot write session to /tmp/vufind_sessions/sess_v15urm7eesl9bcjl06smlqqqse